You are currently browsing the category archive for the ‘technology’ category.
Cardiovascular disease affects more people each year than any other disease or illness. Cardiovascular disease means disease of the heart (cardio) and arteries (vascular). This disease can result in heart attack, stroke, angina or heart failure. The stiffening and hardening of the arteries which makes the heart work harder can occur years or decades before you start experiencing any symptoms. That is why cardiovascular disease is sometimes referred to as the “Silent Killer”.
The most problematic aspect of developing cardiovascular disease is that you don’t know that it’s happening to you. You can’t feel it happening, like catching a cold. There the symptoms are very prominent. You know when you are catching a cold. Cardiovascular disease is another matter. You can’t feel arterial clogging plaque building up, stiffening your arteries and choking off your blood flow to different parts of your body, depriving vital nutrients and oxygen to your cells and organ until it’s too late. You develop angina or have a heart attack or stroke.
It is very important that you do not wait to experience symptoms of cardiovascular disease.
There has been very little preventative test equipment available for early detection of cardiovascular disease, progression or risk. The most common testing available today, although useful, offers little information concerning arterial health. Other state of the art testing equipment currently available is usually found in hospital’s cardiac care units and are either highly invasive (hence risky), extremely expensive, or both.
The Pulse wave Assessment complements the conventional cuff blood pressure measurements and provides additional information on arterial stiffness and performance of the heart. It is able to be used simply in any medical practice and is portable. It is ideally used as part of a preventative health approach, modifying diet, increasing exercise and taking appropriate supplements. Retesting can be done at intervals to monitor progress.
INTERCURE RANKED NUMBER 136 FASTEST GROWING TECHNOLOGY COMPANY ON THE DELOITTE TECHNOLOGY FAST 500 EMEA 2008.
Attributes 1,227 Percent Revenue Growth to Successful Expansion into Retail Stores
New York, N.Y. – January 12, 2009 InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that it ranked Number 136 on the Deloitte Technology Fast 500 EMEA 2008, a ranking of the 500 fastest growing technology companies in EMEA. Rankings are based on percentage revenue growth over five years. InterCure grew 1,227 percent during this period.
“Being named as one of the 500 fastest growing technology companies in Europe, Middle East and Africa is a significant recognition for InterCure and indicative of our continued growth and success over the past five years,” said Erez Gavish, president and CEO of InterCure. “Our launch into the retail market allowed us to expand our business and extend our reach, placing RESPeRATE onto the shelves of the neighborhood pharmacies and into the homes of thousands more hypertension sufferers worldwide.”
“Making the Deloitte Technology Fast 500 is commendable in today’s highly competitive technology industry,” said Karel Bakkes, partner in charge of Deloitte’s Technology Fast 500 EMEA program. “We congratulate InterCure on being one of the 500 fastest growing technology companies in the region.”
InterCure previously ranked 170 on 2007 Deloitte Technology Fast 500.
Overall, companies that ranked on the Technology Fast 500 EMEA 2008 program had an average growth rate of 1,297 percent.
About InterCure Ltd. and RESPeRATE
InterCure Ltd. (Tel-Aviv Stock Exchange: INCR) is disrupting the $42 billion hypertension industry with the world’s first FDA-cleared, OTC blood pressure treatment device, RESPeRATE® (www.resperate.com). In a market where seven out of 10 hypertensives are NOT controlled despite the availability of more than 100 blood pressure medications, RESPeRATE provides an effective adjunctive non-drug therapy with no side effects.
RESPeRATE has gained widespread support of hypertension specialists and has secured regulatory clearance in most key international markets. Ten separate clinical studies have proven the device’s efficacy and safety, and RESPeRATE is now featured in more than 20 popular and professional text books.
With more than 100,000 units sold, thousands of supportive clinicians worldwide and one of the world’s most popular hypertension websites, InterCure is now introducing RESPeRATE into retail pharmacies to increase access to hypertension sufferers.
InterCure has an exciting product pipeline based on its broadly-patented “Device-Guided Breathing” technology platform. This technology enables a systematic reduction in sympathetic outflow of the autonomic nervous system, one of the key underlying causes of cardiovascular disease, insomnia and several other medical conditions.
When I was working in a very stressful role in Corporate Health, my body finally said very loudly “Enough of this folly!”. My blood pressure went through the roof and I ended up having a complete nervous collapse, ending up with chronic fatigue requiring bed rest for 8 months. Fortunately for me, I had someone come to the office and share Resperate with me. I thought it was a great device, well backed by research and introduced its use into our Health Expos. My plan then, and I still see this happening in due time, was to create relaxation rooms for employees and Resperate, among other things, would be available for employees to use when they needed to chill out. When everthing went pear shaped, I had the Resperate to help calm me down (I also developed anxiety and panic attacks). It was such a blessing. I really believe in this product, particularly where stress is a factor in your health issues. Many people, like me, have high BP that does not repond particularly well to medication, and it is very important for our health that BP is as normal as possible.
Using the Resperate is very relaxing. It uses musical notes, initially that change in time with your breathing and then gradually the notes go for longer, and your breathing slows. They say that if breath rate goes down to under 7/minute for 10 minutes or so the autonomic nervous system relaxes. Its like the Resperate pulls the stress out of your body. But there’s more to it than that. The biofeedback device that is strapped around your chest monitors whether you are listening and timing your breathing to the notes. Often people’s mind can wander, even without them knowing it and their breath rate increases. They find themselves thinking about how horrible and mean the neighbour was about the dog barking, concern over the daughters new boyfriend blah blah blah…that stinking thinking has major magnetism…When this happens the Resperate picks up that you are not listening and concentrating and has all sorts of strategies built in to “wake you up” and bring you back on track. While the Resperate has been proven to lower blood pressure, I belive that is just one of the benefits of learning how to spend 15 minutes a day doing nothing but breathing. It is a way to meditate and chill out for the everyday man.